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In recent years, controlled release of drugs has posed numerous challenges with the
aim of optimizing parameters such as the release of the suitable quantity of drugs in
the right site at the right time with the least invasiveness and the greatest possible
automation. Some of the factors that challenge conventional drug release include long-
term treatments, narrow therapeutic windows, complex dosing schedules, combined
therapies, individual dosing regimens, and labile active substance administration. In
this sense, the emergence of micro-devices that combine mechanical and electrical
components, so called micro-electro-mechanical systems (MEMS) can offer solutions to
these drawbacks. These devices can be fabricated using biocompatible materials, with
great uniformity and reproducibility, similar to integrated circuits. They can be aseptically
manufactured and hermetically sealed, while having mobile components that enable
physical or analytical functions together with electrical components. In this review we
present recent advances in the generation of MEMS drug delivery devices, in which
various micro and nanometric structures such as contacts, connections, channels,
reservoirs, pumps, valves, needles, and/or membranes can be included in their design
and manufacture. Implantable single and multiple reservoir-based and transdermal-
based MEMS devices are discussed in terms of fundamental mechanisms, fabrication,
performance, and drug release applications.
Keywords: micro-electro-mechanical systems, drug delivery, microfabrication, implantable MEMS devices,
actuation mechanisms, transdermal devices
INTRODUCTION
The design and development of novel materials and devices for medicine is one of the exciting new
areas of bioengineering and biotechnology, which is rapidly gaining the attention of the scientific
community (Zhang et al., 2011; Hardy et al., 2013; Copes et al., 2019; Hu and de Vos, 2019; Tamay
et al., 2019). Biofabrication is providing scientists and clinicians the ability to produce engineered
devices with desired shapes, chemical composition, and biological functions (Echave et al., 2019;
Scilletta et al., 2019; Debons et al., 2020; Frayssinet et al., 2020). In the last few decades, several
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biomaterials and nanomaterials have been proposed and develop
to this end (Desimone et al., 2010; Scodeller et al., 2013;
Alvarez et al., 2014; Mebert et al., 2017). Indeed, the design
and optimization of new drug delivery systems that may help to
limit multiple application doses and improve patient compliance
is advancing rapidly (Boccardi et al., 2015; Hardy et al.,
2016; Mebert et al., 2016). Biotechnology and bioengineering
are rapidly moving toward the development of personalized
tools to achieve more predictable and optimal treatments
(Orive et al., 2020).
Micro-electro-mechanical systems (MEMS) are technological
devices which can be well-defined as miniaturized mechanical
and electro-mechanical elements creating miniature integrated
systems or devices (Lyshevski, 2002; Villanueva et al., 2016).
They varied from comparatively simple structures having no
moving parts, to very complex systems with numerous moving
elements under the control of combined microelectronics. The
interdisciplinary of MEMS nature exploits from the integration
of a diverse range of technical areas including integrated
circuit techniques, chemistry and chemical engineering,
mechanical engineering, materials science, electrical engineering,
as well as microfluidics, biomedical engineering, and optics
(Judy, 2001). MEMS production technologies uses high
performance processing that usually includes addition or
subtraction of 2D layers on a substrate based on mainly
photolithography techniques and a variety of thin-film deposit
and patterning technologies, together with selective chemical
etching (Madou, 2002).
Current MEMS devices have the capability to sense, actuate
and control on the micro-scale, and produce effects on the
macro-scale. MEMS have been recognized as one of the most
auspicious technologies of the 21st Century and have the future to
revolutionize both consumer products and industry. MEMS are
considered the second micro-manufacturing revolution after the
first revolution based on semiconductor microfabrication. These
microsystem-based devices have the prospective to dramatically
get better all our lives. MEMS can be found in devices ranging
across electronic, communication, and medical applications
(Ho and Tai, 1998; Gardner and Varadan, 2001; Rebeiz, 2004;
Mohammadi Aria et al., 2019). Current MEMS include for
example: inkjet printer heads, accelerometers, computer disk
heads, display chips, optical switches, blood pressure sensors,
biosensors, microvalves, and numerous other products that are
manufactured in great commercial volumes (Kaajakari, 2009).
The experience gained from the early MEMS applications
has tailored their emerging technology for biotechnological
developments including water and environmental monitoring,
DNA sequencing and drug discovery (Bashir, 2004). Novel
drug delivery methods to release a specific dose of a drug
with a certain rate, during an adequate period of time in
the targeted tissue and facilitating patient self-administration
are becoming increasingly necessary (Orive et al., 2003; Geipel
et al., 2007; Ruggiero et al., 2018; Singh et al., 2019; Tharkar
et al., 2019; Chen Y. et al., 2020; Deng et al., 2020; Hwang
et al., 2020). In this sense, advanced biomedical technology will
comprise implantable MEMS devices of proven biocompatibility
(Voskerician et al., 2003), to carefully release drugs into the
body from micro-chambers hosted in the device, eliminating the
need for injections or needles (Grayson et al., 2004; Vasudev and
Bhansali, 2013). The delivery of antibiotics, anti-inflammatories
and analgesics is one such promising application, as also is
the delivery of chemotherapy drugs or even hormones as the
archetypical insulin (Shawgo et al., 2002; Chen et al., 2018). It
is to note that these investigations could be enhanced by the
incorporation of stimuli sensitive and/or targeted nanocarriers
(Couvreur, 2013; Gonzalo et al., 2013; Jhaveri and Torchilin,
2014; das Neves et al., 2015; Kumar et al., 2018) within MEMS
devices and the use of microfluidic organ-on-a-chip platforms
for testing these drug delivery systems (Bhise et al., 2014). An
envisioned generation of MEMS chips could also interact with
MEMS and hydrogel-based sensors embedded in the body itself
to respond to own internal signals (Caldorera-Moore and Peppas,
2009; Peppas and Van Blarcom, 2016).
This review introduces the field of micro-electro-mechanical
devices for controlled drug release applications and is organized
as follows. A comprehensive implantable MEMS devices
description from single to multiple reservoirs is presented
together with their actuation mechanisms and current
applications and challenges. Transdermal delivery devices
are particularly described in the subsequent section. Finally,
some concluding remarks and perspectives are outlined.
IMPLANTABLE MEMS DRUG DELIVERY
DEVICES
Drug delivery implantable devices are characterized by
containing reservoirs loaded with drugs to be released, which are
the most critical parts of them. Reservoir material constitution
must not only be biocompatible on the outside but also inert
on the inside, as this part is directly in contact with the drugs
to be delivered (Grayson et al., 2004; Lee et al., 2018). Hence,
polydimethylsiloxane (PDMS), polyacrylamide (PAA), medical
grade silicone rubber and Pyrex© are the most widespread
materials suitable for reservoir construction. They have well
known physicochemical properties that direct new developments
toward their utilization. Their biocompatibility, bonding and
optical transparency are some of the desirable characteristics
found in these kinds of materials (Uvarov et al., 2016a). Recent
microfabrication processes offer a lot of advances in size
terms to achieve admissible reservoirs (Randall et al., 2007).
In this sense, reservoir size should be big enough to load the
appropriate drug doses and small enough to ensure that actuation
mechanisms are effective in the release of drugs and that the
total size of the device is not significantly increased, considering
their implantable destination. Nowadays, miniaturization of
implantable devices is truly of great relevance (Staples et al.,
2006). As, on one hand, devices first functionality tests are
developed in small laboratory animals, and on the other hand,
the final target is human tissue, the reduction of device size is
always welcome. In order to accomplish drug delivery in exact
doses and in a controllable manner, MEMS drug delivery devices
are usually based on single or multiple reservoirs where drugs are
loaded (Zhou et al., 2012).
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Single Reservoir-Based Devices
The most recent reports of MEMS devices for drug release
applications have proposed to use a single reservoir to load
different drug formulations. In these devices the total amount of
drug contained in the reservoir is dosed by pumps using different
actuation mechanisms to achieve an exact and controlled release
of the drug. Different materials were employed for reservoir
constitution, mostly depending on the actuation exerted (Zhang
and Wei, 2016). In this section recent advances in single
reservoir MEMS drug delivery devices are discussed based on
their actuation mechanisms. A summary of them can be found
on Table 1.
Micropump-Based Devices
Micropumps, essential components of microfluidic devices, were
proposed to achieve the aim of releasing a specific dose of
a drug with a certain rate and during an adequate period of
time in a targeted tissue as they are responsible for generation
TABLE 1 | Single reservoir-based MEMS devices for drug delivery applications.
Actuation
mechanism
Device dimensions Drugs tested Main materials used References
Piezoelectrical (8 × 8) mm × 100 µm Water based fluids Silicon wafer Au PDMS Rao et al., 2018
Piezoelectric (700 × 130) µm N/A PZT-5H
Quartz
PDMS
Sateesh et al., 2018





Johnson and Borkholder, 2016




Forouzandeh et al., 2019
Electrochemical 10 mm long, 10 mm








Song et al., 2017
Electrochemical 20 × 15 × 8.1 mm,






Cobo et al., 2016
Magnetic 5 mm× 3 mm× 12 mm
and





Zachkani et al., 2015
Electrochemical 10 mm× 10 mm× 2 mm Adrenaline PDMS
PO
Pt/Ti
Liu et al., 2015
Transdermal 21 mm Ø N/A PDMS
Acrylic
Silicon
Cantwell et al., 2014
Electrochemical 13 mm× 13 mm× 3.5 mm Doxorubicin hydrochloride PDMS
Silicon wafers
Ti/Au
Song et al., 2013
Electrochemical N/S N/S Parylene Pt/Ti Soda lime wafer Nafion R© Sheybani et al., 2013a






Gensler et al., 2012
Magnetic (6 Ø × 0.59) mm Methylene blue PDMS
Iron oxide nanoparticles
Pirmoradi et al., 2011a
Magnetic (6 Ø × 0.59) mm Docetaxel PDMS
Iron oxide nanoparticles
Pirmoradi et al., 2011b
Piezoelectric (8 × 8) mm × 100 µm Water based fluids Silicon wafer Cr/Au PZT Geipel et al., 2007
N/S, not specified; N/A, not aplicable; Au, gold; Pt, platinum; Ti, titanium; Cr, chromium; Cu, copper; PDMS, polydimethylsiloxane; PO, polyolefin; PTFE,
poly(tetrafluoroethylene); PZT/PZT-5H, piezoelectric materials; MDX4-4210, biomedical grade silicon elastomer; TEOS, tetraethyl orthosilicate.
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of fluid movement (Kalra and Mashuq un, 2017). Small and
compact pumps can be incorporated into delivery devices and
precisely control the dosage to be delivered into the body. The
micropumps can be programmed for instance to administer
drugs at a constant rate throughout the day, thus eliminating any
surges or deficits of the drug in patient’s bloodstream. Dosage
and timing are critical to the study of drug effects on the body;
hence, selecting an adequate pump is critical to optimal device
function. Numerous developments have been reported in this
way. Actually, a noticeable large number of designs allow the
combination of uncountable type of arrangements to improve
MEMS drug delivery system (Joshitha et al., 2017). Nowadays,
pump size, low heat generation, precise metering capability,
small power consumption, and the ability of system integration
are critical parameters for life science applications (Cobo
et al., 2015). Micropumps are usually classified into mechanical
(displacement) and non-mechanical (dynamic). Piezoelectric,
magnetic, and those based on materials phase change are
among the most reported mechanical micropumps. On the
other hand, the most relevant non-mechanical micropumps
reported are those based on electrochemical induced forces to
move fluid. All these types of micropumps can be designed
to be miniaturized for implantation purposes. In addition
to their sizes, the need of an external power source and
energy required for operation become critical. These factors
will determine the final size of the device and the feasibility
for implantation.
Mechanical Micropumps
Mechanical micropumps use the movement of components
such as oscillating diaphragms to pump a fluid by applying
pressure (Mohith et al., 2019). These, also called displacement
micropumps, consist of two main components for fluid pushing
and halting and develop a pulsating flow due to their periodicity.
Their general construction includes a flexible membrane or
diaphragm, an actuator, a pumping chamber, an inlet, and
an outlet. The oscillatory or reciprocal movement of the
membrane is driven by a physical actuator that produces the
pressure difference for fluid pumping. Piezoelectric, magnetic,
and material phase change, are among the physical driving forces
used in mechanical micropumps based MEMS devices for drug
delivery applications.
Piezoelectric-based micropumps. In conventional piezoelectric
micropumps, a middle membrane goes up and down being
driven by the activation of an actuator. These membranes are
commonly made of lead zirconate titanate (PZT), an artificial
ceramic material with a strong piezoelectric effect. These kinds of
pumps alternate suction and compression phases causing the flow
entering and exiting the chamber through valves. Piezoelectric
pumps are the most common devices made since 1990s. Smits
(1990) originally described a three piezoelectric valve peristaltic
pump. In this development the pump was constituted by a
piezoelectric disk attached to a glass membrane, which was
carried on a silicon wafer supported by a flat glass bottom plate.
Glass membrane attaching to the silicon wafer was performed by
anodic bonding and the device was built by etching techniques.
At the beginning of any pumping cycle, the piezoelectric disk
was electrically deflected in a convex shape. This deformation
allowed sucking of the medium from the inlet into the generated
cavity under the piezoelectric material, which was therefore
connected with the backside channel and the inlet tube. The
next piezoelectric membrane was convexly deflected in the same
way as the previous one, allowing the medium to flow into the
hollow under the second membrane. After that, closing of the
first element was performed by decreasing its voltage to zero
or negative, and the medium was gathered under the second
element. Later, the third membrane was deflected, causing the
channel on the back to be connected with the outlet. After second
element voltage shut down, the stored fluid was pushed in the
channel toward the final open element. Finally, by decreasing
the voltage of this third element the medium is free to flow
through the outlet pipe. At the end of the pumping cycle the three
membranes were closed and a new one could start. With this
design a high pumping rate of up to 100 µL min−1 was reported
to be theoretically feasible.
Going forward to recent years, a theoretical design and
simulation of a single piezoelectric micropump composed by
zirconate titanate (PZT)-5H material, quartz and PDMS was
reported by Sateesh et al. (2018). Although piezoelectric pumps
offer fast response times and high forces, high voltage needs
and special care must be taken into account when mounting
PZT discs. The aim here was to reduce the power consumption
by means of flow speed increase. Laminar and turbulent flows
were considered in the analysis of device structural materials.
The authors were especially interested in analyzing laminar flows
resulting when pumping biological media. The analysis was made
by changing the inlet, outlet, and channel dimensions. PDMS was
chosen as the material to support the bending of the piezoelectric
membrane owing to its transparency, high yield strength,
good flexibility, inexpensiveness and biocompatible properties.
This would be placed over two electrodes, ground and active.
A quartz channel with inlet and outlet on PDMS membrane
was considered. Application of voltage to the electrodes would
cause the piezoelectric material to deform and vibrate, pumping
the drug out of the channel. This study demonstrated that
increases in channel and outlet widths resulted in lower flows.
Although this design offers flexibility and controllability for
drug delivery platforms (Khare and Singh, 2014), even reducing
component dimensions, low pumping rates were achievable with
either turbulent or laminar flow regimes when using this single
piezoelectric element. A variation of this design in which the
device is integrated with a micro-needle to deliver the pumped
drug into the patient’s body was analyzed and simulated (Rao
et al., 2018). Reliability, biocompatibility and required fabrication
procedures were considered in the election of silicon as micro-
needle material. Much higher flow rates were achievable here
(up to 4.7 mL min−1) by analyzing changes in voltage and
piezoelectric materials.
In another approach, a two-stage micropump, designed for
metronomic drug delivery was reported (Geipel et al., 2007;
Mahnama et al., 2014). This system had two back to back active
valves with two separate piezo-actuators and worked in a three
phase regimen, including: re-fill, transfer, and delivery phases.
The device was fabricated in a two bulk silicon process which
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utilized standard lithography and included chromium/gold
electrodes. The cavities and the fluidic channel ports were made
by KOH etching, while the pump chamber and the valve lips were
fabricated by deep reactive ion etching in separate wafers which
were then bonded by low temperature silicon wafer bonding.
This design stands out for its independence from the flow back
pressure (which was tested in the range of 0.1–50 µL min−1),
allowing a precise volumetric dosing of aqueous fluids.
Recently, a millimeter-scale piezoelectric pump with
built-in compliant structures was designed, fabricated, and
experimentally tested by a group of researchers (Bao et al., 2019).
This device had a chamber of 12 × 1.1 mm (diameter × height),
a piezoelectric vibrator, and two pairs of valve featured elements
on the flowing channel (Figure 1). PDMS, polyethylene,
parylene, SU-8 photoresist, hydrogel, among others, were
considered for device building. The manufacturing methods
included computer numerical control (CNC) machining, 3D
printing technology, and MEMS fabrication methods such as
wet etching and deep reactive ion etching. The flow channel
was 2 mm in width and 1.5 mm in height. The entire device
was made in two parts: (1) the upper part that mainly included
a piezoelectric vibrator mount, and two grooves at its ends;
(2) the lower part that included a pump chamber, inlet and
outlet channels, four grooves to mount the valve featured
elements, and two grooves at the end of the flowing channels.
Both parts were bonded by ultraviolet epoxy. Performance
results showed that the flow rate positively correlated to the
voltage and a maximum of 3.6 mL min−1 at 210 V and 80 Hz
was achieved. The authors did not described the design of a
micrometer sized pump but considered that the valve featured
elements were not importantly limited by the size of the
channel and that the developed piezoelectric pump will be
able to be miniaturized by MEMS processing methods turning
it a good candidate for microfluidic applications like drug
delivery systems.
Another recent study analyzed the theoretical performance
of a piezoelectric micropump for drug delivery applications
(Farshchi Yazdi et al., 2019). The proposed micropump is based
on silicon diaphragms actuated at 60 V and on flow input and
output passive valves. The most important features of this design
were that the device could be fabricated using two silicon wafers
and that the use of an elliptical chamber could decrease dead
zones and increase outflow. The performance and efficiency
of the micropump were improved by optimizing geometrical
features, which was enabled by the computational model. In
this way, an outflow of 1.62 µL min−1 at 10 Hz was increased
up to 2.5 µL min−1, paving the way for the development of
micropump prototypes for biomedical applications following the
proposed design.
Piezoelectric micropumps have shown to offer high actuation
forces, fast response times and precise volumetric dosing of
aqueous fluids. However, their manufacture is complex and
special care must be taken in processing and mounting PZT
discs. They also require a comparatively high actuation voltage.
There are no reports of implantable MEMS devices based on
piezoelectric pumps which were tested in vivo for drug delivery
and many of the studies are still in the simulation stage.
Magnetic-based micropumps. Micro-electro-mechanical systems
drug delivery devices are usually based on embedded batteries
for operation and therefore the overall size is conditioned by the
electronics and battery size, which limit miniaturization of these
devices. In this sense, the development of some drug delivery
devices controlled by magnetic forces was reported (Pirmoradi
et al., 2011a,b). In one case the device consisted of magnetic
PDMS membranes with laser drilled opening sealing micro-
reservoirs filled with drug, which were actuated externally by a
magnetic field (Figure 2A). The magnetism of PDMS membranes
were given by iron oxide nanoparticles coated with a fatty acid
surfactant which were dispersed in the polymer. Drug reservoirs
were fabricated by molding PDMS using photolithography.
Briefly, spin coating of a layer of photoresist was followed by a
selectively UV exposition. By pouring of the pre-polymer mix
on the patterned silicon substrate and pealing it away from
the mold, cavities were generated into PDMS that were ready
for drug loading (Figure 2B). The reservoir was bonded to the
magnetic PDMS membrane using a sacrificial layer of polyacrylic
acid. The magnetic composite membrane was deposited by
spin-coating. Surface wettability of PDMS surfaces, which is
naturally hydrophobic, was modified by using bovine serum
albumin to allow reservoirs filling with drug dissolutions. The
actuation was triggered by application of an external magnetic
field which concavely deformed the membrane and increased
reservoir pressure releasing the drug. Initially, the drug tested
was methylene blue owing to its high solubility, high UV-
Vis absorptivity which enable and a clear observation of the
released drug (Pirmoradi et al., 2011a). The magnetic field
for membrane actuation was applied by a rotating permanent
magnet. The magnitude of the external magnetic field and
the number of actuation events were adjusted to control the
amount and the time of released drug. This later feature was
determined by an on-demand application of the magnetic field
(Figure 2C). In a practically simultaneous study by the same
authors, this device was used for controlled release of docetaxel
(Pirmoradi et al., 2011b), a chemotherapeutic drug that has
antiangiogenic effects at very low concentrations and required a
localized administration to treat diabetic retinopathy. Constant
and reproducible release rates were achieved over more than
a month, with negligible leakage of drug when the device was
not magnetically actuated. The biological activity of the drug
released from the device was confirmed in vitro by analyzing its
antiproliferative effect.
Based on the same principle, a cylindrical MEMS device
magnetically actuated was reported as another option. In this
study, again two drugs with different solubility in aqueous
solutions were studied: the high soluble methylene blue and the
low soluble docetaxel, which is also commonly used to treat
prostate cancer (Figure 3; Zachkani et al., 2015). The drug
delivery device was formed by a drug reservoir fabricated in
PDMS, a PDMS membrane, a rectangular magnetic structure and
the covering. The modeling was achieved by 3D-printed molds
made from a thermoplastic material called acrylonitrile butadiene
styrene. The magnetic structure was composed by two layers
of iron oxide magnetic nanoparticles between PDMS layers.
By the application of magnetic fields, the magnetic structure
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FIGURE 1 | The working principle of the proposed lead zirconate titanate (PZT) pump: (A) the pump chamber in suction stroke; (B) the inhaling principle during
suction stroke; (C) the pump chamber in compression stroke; (D) the exhausting principle during compression stroke; (1) the piezoelectric ceramic; (2) the brass
substrate; (3) the pump chamber; (4) the compliant structure; (5) the outlet channel; (6) the inlet channel. Reproduced from Bao et al. (2019) with permission from
MDPI Open Access Journals.
deflected the membrane and allowed the drug to be release in
the covering through an opening, similar to what was initially
described by Pirmoradi et al. (2011a). Drugs were then delivered
by diffusion through a large opening in the covering. On-
demand and reproducible drug release rates were reported to be
achieved in this study.
The salient property of these magnetically controlled devices
is that they do not need a battery to operate. Instead, they
are designed to be actuated by magnetic fields with intensities
ranging from 135 to 255 mT. These values are much higher than
the magnetic field margins internationally accepted as safe for
human health under chronic exposures, which are in the order
of µT (IEEE, 2002; World Health Organization [WHO], 2007).
Although potential magnetic field damage would depend on the
time of exposure, which in this case would be short but repetitive,
none of the devices presented in this section were tested in vivo,
nor the potential harmful effects of the magnetic field application
needed for device actuation studied. Another important thing to
mention is the complications that would arise with the need for
a magnet to activate implanted devices from outside the body,
especially in terms of lack of portability and comfort.
Phase change-based micropumps. Phase change actuation is
based on materials which undergo a phase transition caused
by a heating cycle, such as gallium or paraffin. Heat is
usually generated through metals micro heaters deposited onto
substrates. These micropumps can offer programmable ultra-low
flow rates with controllable profiles and low power consumption.
In this context a planar micropump based on gallium phase-
change actuation which exerts occlusion of the flow channel
through expansion during solidification was described (Johnson
and Borkholder, 2016). In this way isolation of the drug
reservoir was enabled without consuming energy. The silicon-
based MEMS device was 7 × 13 × 1 mm and included fluidic
channels, pump chambers, in-plane interconnects and aluminum
heaters and contacts. The pump was fabricated by using a
combination of MEMS techniques (plasma-enhanced chemical
vapor deposition (CVD), plasma etching, wet etching, etc.) and
the gallium actuator was produced by additive manufacturing
direct write technologies. It was coated with biocompatible
Parylene-C, critical for implantable applications. Four actuators
were used to propel the fluid peristaltically by transferring
momentum to diaphragms made of tetraethyl orthosilicate and
Parylene-C. The pump rate was controlled via the frequency of
the control circuit and reached a large range (18–104 nL/min)
at an efficiency of 11 mJ/nL, which could be theoretically
reduced by using a gallium-indium alloy and the addition of a
close loop control.
In a similar but more recent micropump design, peristaltic
pumping was achieved by expansion and contraction of paraffin
wax located in three chambers, which sequentially produced
compressing of a microtube (Forouzandeh et al., 2019). The
chosen actuation material has a stable phase-change behavior
and high-pressure actuation and its melting point can be chosen
by selecting the appropriate molecular weight. The mechanical
components of the micropump were designed for ultra-low
power operation and built using direct-write 3D printing
technology around the microtubing, directly on the back of a
printed circuit board assembly which provided microprocessor
control of actuation and Bluetooth wireless communication. Six
resistive heaters and thermistors were used to generate a linear
template for three chambers and a groove for the microtubing
was placed between them. The overall micropump size was
8 mm × 8 mm × 3 mm. The micropump achieved a resolution
of delivery in the range of 10–100 nL/min, in the presence of up
to 10× larger than physiological backpressures and by changing
the actuation frequency, according to the in vitro characterization
results. The device also showed biocompatibility both in vitro and
in vivo. It was implanted in mice and results indicated functional
sodium salicylate delivery near the round window membrane
of the ear. This proof of concept success in mouse which has
a cochlea volume of around 620 nL, stimulates translational
opportunities. Using appropriate scaling of the microtubing size
and actuator volume, the micropump would be scalable for use
in larger species. However, device long-term implantation with
periodic drug delivery still needs to be studied.
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FIGURE 2 | (A) Principle of operation, (a) before actuation, (b) drug release after magnetic field application. (B) Schematic illustration of actuation mechanism of a
suspended magnetic membrane under an external magnetic field using a permanent magnet. (C) Major fabrication steps of a magnetically actuated drug delivery
device. Adapted from Pirmoradi et al. (2011a) with permission from The Royal Society of Chemistry.
FIGURE 3 | Conceptual diagram of the proposed minimally invasive drug delivery device showing (A) device components, (B) device under no magnetic field, and
(C) actuated device under an applied magnetic field. Reproduced from Zachkani et al. (2015) with permission from The Royal Society of Chemistry.
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Phase change micropumps offer the advantage of blocking
flow in the off state, allowing the drug reservoir to be isolated
from the delivery target without consuming energy. They
also offer a relative low actuation voltage. Among their main
drawbacks slow response time, especially during the cooling
process, the low frequency of operation and the limited materials
required for actuation should be mentioned.
Non-mechanical Micropumps
A non-mechanical micropump exerts forces directly on a liquid
and does not involve any kind of structural moving as a
part of its operation to flow the fluid. In these systems, a
non-mechanical source of energy is converted into kinetic
energy (Meng and Hoang, 2012). Non-mechanical micropumps
usually have a limited flow rate, slower response compared
to mechanical micropumps and often require interaction with
a working solution with particular electrical properties, such
as conductivity. However, they have shown to be very useful
in devices for drug delivery applications owing to their
low power consumption. Non-mechanical micropumps can
be actuated by electro-hydro-dynamic, magneto-hydrodynamic,
electro-osmotic or electrochemical forces, being the last ones the
most relevant in drug release applications.
Electrochemical-based micropumps. Electrochemical actuation is
based on reversible electrochemical reactions. Reduction by
electrolysis in an aqueous electrolyte solution enables gas bubble
generation and expansion of the reservoir in which that solution
is contained. To achieve this, electrochemical-actuator based
micropumps include integrated electrodes which are commonly
fabricated using photolithography and lift-off process on silicon
wafers. These devices usually used titanium/platinum electrodes
deposited using an e-beam evaporator (Tng et al., 2013; Liu
et al., 2015) or by magnetron sputtering (Uvarov et al., 2016a).
In general terms, when a current is supplied to the electrodes,
the electrolysis splits the water molecules, generating hydrogen,
and oxygen gases (Gensler et al., 2012; Song et al., 2013;
Anderson and Davis, 2015). The formation of the gases increases
the pressure within the pump chamber, causing the expansion
of a flexible membrane and pushing out the contents of the
drug reservoir next to the reaction chamber. This mechanism
enables drug dispensing, the dose of which would depend on
the concentration of drug solution and on for how long the
current is supplied to the electrodes. The drugs are prevented
from oxidation damage by electrochemical reactions through a
separation of the pump chamber and the drug reservoir by a
flexible membrane (Tng et al., 2013). Besides, after the current
is turned off, the Pt/Ti electrodes catalyze the recombination
of gases into water. As a result, a refillable reservoir requires a
reduced amount of elements, offering in this way, a sustainable
solution to individualized drug delivery.
In this context, an electrochemical micropump composed of
metallic electrodes deposited on a glass substrate and a PDMS
structure including channels for the electrolyte was reported
(Uvarov et al., 2016a). These two parts were manufactured
separately and were then connected. Soft lithography technique
was used to fabricate the PDMS structure, while deep RIE was
utilized for diffusers and channels. Researchers reported two
main problems found after preliminary testing of this device.
On one hand, after several hundreds of cycles of alternating
polarity testing the electrodes underwent fast degradation. On the
other hand, the flow rate measured was significantly lower than
expected. This was attributed to the softness of PDMS material,
as an important part of the produced gas was spent in inflating
the chamber instead of pumping. For these reasons, the authors
concluded that the chamber of the micropump needed to be
fabricated with a stiffer material, as well as the electrodes require
choosing an appropriate material more resistant to degradation.
In a subsequent approach, the same research group tested a
new version of this device (Uvarov et al., 2016b). Two types of
electrodes were used: a platinum electrode and one made of Ti/Al
layers. Testing in the alternating polarity mode regime evidenced
an increased frequency operation of the pump because of very
short gas termination time. Like on the previous assay, the flow
rate was lower than expected due to PDMS deformation. While
platinum electrodes were fast degraded, almost no damage was
found on the aluminum electrodes coated with a titanium layer.
Researchers observed that short voltage pulses of alternating
polarity generated transient microbubbles as a result of the merge
of nanobubbles of H2 and O2. These microbubbles contain
a stoichiometric mixture of gases and ignite spontaneously,
liberating enough energy to drive the pump. The flow rate
measured in this regime was significantly higher than the one
without the formation of these transient microbubbles.
In this context, the same authors continued studying more
deeply the dynamics of the gases inside the chamber (Uvarov
et al., 2017). As a result of the analysis of this phenomenon,
they conclude that the device can be further improved by
making some modifications. Firstly, higher voltage amplitude
could help to reach a shorter pumping cycle. Secondly,
the cylindrical symmetry of electrodes was able to reduce
uncorrelated explosions by distributing the nano-sized bubbles
more homogenously in the chamber. Thirdly, the operating
characteristics could be improved by selecting a more suitable
material for the chamber and utilizing aluminum electrodes.
They concluded that these exploding microbubbles could be very
useful for electrochemical actuators and pumps of varied designs
which could include specific bubble force-activated membranes
(Huang et al., 2012).
Another single reservoir drug delivery MEMS design based
on an electrolytic actuator was developed and tested in vitro
for programmed administration of the chemotherapy drug
doxorubicin (Figure 4A; Song et al., 2013; Tng et al., 2013). The
device was composed of two chambers: a drug reservoir with a
cannula and a pump chamber, the last one containing a set of
interdigitated gold electrodes. The fabrication was carried out
in three separate parts and components were then assembled
(Figure 4B). The electrodes consist of Ti and Au layers deposited
by electron-beam evaporation on a silicon substrate. The rest of
the device was fabricated individually with PDMS using a micro-
machined mold and then connected also using PDMS, which
was selected as it is highly biocompatible, cost-effective, flexible,
optically transparent and easy to fabricate. A needle syringe was
used to fill the drug reservoir with doxorubicin solution, as well
as to fill the pump chamber with sterile deionized water, which
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FIGURE 4 | (A) Implantable MEMS electrochemical drug delivery device: (a) schematic view of the device and delivery, (b) electrochemical actuation of the flexible
membrane, and (c) photo of a prototype model showing the electrode housed within the pump chamber and the drug reservoir lying on top, connected to the
cannula. (B) Three-part design of the implanted drug delivery system: (a) the drug reservoir together with a cannula, (b) the flexible membrane, (c) the electrodes,
and (d) fully assembled device. Adapted from Song et al. (2013) with permission from John Wiley and Sons.
worked as the electrolyte for the electrochemical actuator. The
device was refilled after each test by the same method. Besides,
the authors studied the energy losses undergone by the fluid in
the transition from the reservoir to the cannula. They simulated
the flow and fine-tuned the fabrication in order to minimize
the losses. Because of that, the cannula was fabricated at the
corner rather than the center of an edge. The device was tested
in vitro with different programmed administration schedules of
doxorubicin using two pancreatic cancer cell lines. As a result,
cancer cells growth was successfully inhibited, demonstrating the
capability of programmed drug delivery.
Another microdevice, presented by Liu et al. (2015), was
fabricated and tested in vivo in rodents. The authors made an
extensive analysis of previous works to find the most efficient
design in terms of size, localized release and re-implantation
time. Instead of using multiple smaller reservoirs, they utilized
a single large reservoir system in order to resolve the dosing
challenge. PDMS molded using SU-8 photoresist was used for
the fabrication of a thin-rounded drug reservoir. This design
was selected to improve biocompatibility during the insertion
of the device, as this shape reduces irritation and extrusion
under the skin and tissues. Besides, a long polyolefin cannula
was added to the reservoir to avoid the need of implanting the
whole device under the skin. A nano-sized sandwiched Pt/Ti
multi-layer electrode actuator was utilized in order to enhance
the actuation lifetime. Moreover, a thick layer of Ti was settled
on the top to protect the electrode from the delamination
process. Two thin copper wires were attached to electrodes using
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silver adhesive conductive paint. The biocompatibility and drug
delivery application was assessed by subcutaneous implantation
of the cannula on the abdominal cavity of 12 Kunming mice.
The evaluated drug consisted of a phenylephrine formulation,
which could achieve the expected increase on mice blood pressure
and was comparable to traditional administration by the syringe
injection method.
An interesting approach in which the electrochemical actuator
was based on Parylene bellows containing water and two
interdigitated platinum electrodes was described in a series of
reports (Gensler et al., 2012; Sheybani et al., 2013a; Cobo et al.,
2016). The pressure, increased by application of electrical current
to these electrodes, deflected the bellows which were placed
inside drug reservoir, turned on a one-way check valve, which
was introduced to guarantee appropriate flow regulation, and
discharged the drug solution out of the reservoir through an
attached catheter to the targeted site (Figure 5). The aim of the
bellows was to detach the electrolysis reaction from the drug
content to avoid chemical interactions. Dose requirements and
desired flow rate for specific applications were used to determine
the time the current was applied. In the first of these reports
a prototype intended to be used in rodents was described and
characterized (Gensler et al., 2012). The device had a refillable
drug-containing reservoir made using silicone rubber casting in
acrylic molds, a material with broad drug compatibility, ease
and inexpensive fabrication and potentiality to avoid irritation
and erosion of surrounded tissue due to rounded features. The
interdigitated platinum electrodes were deposited by electron-
beam evaporation. The optimized Parylene-C bellows had two
convolutions, were fabricated on a glass substrate by a molding
process involving polyethylene glycol and PDMS and their
dimensions was selected for dead volume minimization and
maintenance of sufficient drug volume delivery. The bellows
actuator was inserted in the reservoir through a slot made on
its wall. A biomedical grade elastomer was used to stick the
bellows actuator to the base and seal the reservoir. The fully
packaged device was cured applying temperature and a needle
was used to fill the reservoir. It showed to consume around
3 mW when 1 mA was applied, with a maximum flow rate
of c.a. 4.7 µL min−1. Between delivery pulses, a period of
45 min was needed to allow recombination of gases to water
and bellow deflation. This study demonstrated that the fabricated
device could be used for drug release in mice with controlled
volume and delivery rates. It also showed preliminary results
on chronic delivery of anti-cancer siRNA-gold nanoplex-based
drug. However, the authors questioned their design in terms of
lack of reservoir rigidity, reversed leakage of valves and failure in
micropump repeatability.
A similar and improved version of this device was developed
by the same research group, utilizing a wireless 2 MHz
class D inductive powering system (Sheybani et al., 2013a),
and showing to be highly effective for rapid and repeatable
bolus delivery. Among improvements, polypropylene was used
to fabricate 1 mL-reservoirs and platinum electrodes were
coated with Nafion R© for repeatable and controlled intermittent
pumping. Researchers characterized the performance of actuators
under continuous pumping conditions, utilizing several bellows
configurations at different currents. They found that the flow
rate depended linearly on applied current, so the selection of the
current magnitude determined the flow rate. Besides, the actuator
operating range was limited by the mechanical properties of the
bellows. Furthermore, the recombination of gases into water,
which is an imperative factor for repeatable actuation, was
also studied for Nafion R©-coated and bare electrodes. Solubility
of oxygen and hydrogen gases in Nafion R© was superior to
the one in water. As a result, diffusion to the electrode
surface was facilitated, hence, recombination was promoted
and increased in Nafion R©-coated electrodes in comparison to
uncoated electrodes. This higher electrolysis efficiency, facilitated
by the Nafion R© coating led to higher flow rates reaching more
than 100 µL min−1, though increasing the power up to 25 mW.
Lastly, real-time pressure measurements were accomplished to
investigate how physiological temperature, back pressure, and
drug solution viscosity affected delivery performance.
This design was further miniaturized to build an implantable
wireless infusion micropump for chronic drug delivery and
evaluation of cancer therapies in small research animals like
rodents (Cobo et al., 2016). To attempt this, operation was
achieved by reducing actuator power consumption to 1 mW by
a class E wireless inductive powering transmitter. The device was
capable of dispensing up to 185 µL of drug solution and achieved
reliable low flow rates in the range of µL/min, which are relevant
for cancer therapies. Furthermore, consistent performance was
demonstrated for 30 days under a simulated in vivo environment
considering back pressure, viscosity and temperature, resulting in
less than 4% variation, which was appropriate for its function.
A recent important contribution within electrochemical
actuator-based devices was attempted by a battery-less
implantable drug delivery system with the interesting property
that powers itself with biokinetic energy (Song et al., 2017).
The device consisted of an electrochemical microfluidic pump
powered by a triboelectric nanogenerator (TENG). The TENG is
capable of using ambient mechanical energy and transforming
it into electricity through contact electrification combined to
electrostatic induction (Tetteh et al., 2014; Tang et al., 2015). In
this work, two layers of copper patterned with radial arrayed
strips worked as the rotator and the stator. In between, a
layer of poly (tetrafluoroethylene) (PTFE) film represented
the electrification material. This TENG was connected to the
drug pumping system by wires. The electrochemical pumping
system was composed of a PDMS reservoir, a PDMS microtube
and a set of gold electrodes on a silicon substrate (Figure 6).
Hence, with TENG rotation, the copper rotator slides along the
PTFE film, while injecting electrons into the film as a result of
the contact electrification. The potential difference generated a
current that was then transformed, rectified and applied to the
gold electrodes of the pump. The potential on these electrodes
split the water, thus hydrogen and oxygen gases pressurize the
reservoir, and pumped out the drug contents. The drug release
speed correlated with the gas production rate in electrolysis,
which was defined by the electrons generation rate in TENG.
The researchers measured pumping flow rates from 5.3 to
40 µL min−1 at different rotation speeds of TENG. Furthermore,
the functionality of the fabricated device for ocular drug delivery
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FIGURE 5 | (I) Bellows-based electrochemical micropump device with an externally refillable inert reservoir. (II) Flexible bellow and the arrangement of electrodes in
the inner part of it. (III) Electrolysis produces gas release that increases the internal volume of the chamber inside de bellow. (IV) As bellows inflate, drug solution is
dispensed through a catheter.
was assessed using human hand motion as the power source.
The device was tested ex vivo in porcine eyes by dispensing a
suspension of fluorescent microparticles, which could be imaged
for delivery tracing. Therefore, the authors offered here a novel
way of self-powering an implantable device, eliminating the need
of batteries and making use of biokinetic energy.
Electrochemical micropumps are relatively simple to fabricate
and they can be easily integrated with microfluidic systems.
They offer a continuous and smooth drug delivery and a
large mechanical displacement with low power consumption.
Their major limitation is in the possibility of generated
bubbles to collapse into water causing an unsteady and
unreliable drug release.
Acoustic-based micropumps. Recently, a great deal of attention
has been focused on acoustic bubbles and acoustically oscillating
solid structures, which have been postulated to address some
drawback of other pumps, especially to precisely control the
flow rate. The applications of bubble-based micropumps have
significantly risen in recent years, mainly due to the ability
to integrate an acoustic-based pump and to convert the
acoustic streaming into a pumping flow. The oscillation of
microbubbles generates a flow pattern, which is affected by the
gas compressibility and the acoustic force. This phenomena was
employed to create efficient micromixers (Lin et al., 2019a),
functional particle-polymer composites for accelerated heat
dissipation (Lu et al., 2019) or applied to perform single cell
analysis in a novel 3D design (Lin et al., 2019b).
Interestingly, a pump that utilizes acoustic streaming induced
by localized fluid–substrate interactions can generate stable
unidirectional flow (nanoliter/second) with a high degree of
precision owing to the developed digital regulation. Moreover,
it can handle aqueous and viscous solutions (Wu et al., 2019).
Furthermore, Gao et al. (2020), reported for the first time a
micropump with the ability to pump fluids in different directions
inside a microfluidic device. An interesting feature of this design
is that the flow direction was precisely controlled in the device
with the frequency and voltage applied to the actuator.
However, there are drawbacks associated with acoustic-
based pumps. For example, the bubble’s size would be
affected upon time resulting in changes in the resonant
frequency of the bubbles. In this sense a great deal of efforts
were made to develop theoretical models that would allow
the identification of the resonant frequencies and viscous
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FIGURE 6 | Structural designs and photographs of the TENG and the implantable drug delivery system (iDDS). (A) Schematic illustration of the TENG-based iDDS.
(B) Schematic illustration of the parts in TENG. (C) Schematic illustration of the parts in iDDS. (D) Photograph of the TENG packaged in glass epoxy. The scale bar
indicates 10 mm. (E) Photograph of the iDDS. The scale bar indicates 10 mm. (F) Side-view photograph of the iDDS. The thickness measured is 2 mm. (G)
Photograph of the iDDS on a human hand. Reproduced from Song et al. (2017) with permission from John Wiley and Sons.
dissipation factors of bubbles (Gritsenko et al., 2018). Finally,
the great potential of acoustic-based pumps in terms of
high-precision, small volume, possibility to be programmable
and low cost allows to envision its great potential for
precise drug delivery.
Multi-Reservoir-Based Devices
Another group of MEMS devices for drug release applications
proposes the use of multiple reservoirs in which each reservoir
is aim to provide a single dose of the loaded drug (Sutradhar and
Sumi, 2016). Different approaches are discussed here based on
their actuation mechanisms and summarized in Table 2. In these
devices the amount of drug contained in each reservoir is usually
completely released in an exact and controlled manner. This
is generally achieved by different actuation mechanisms which
promote dissolution or rupture of reservoir capping membranes.
However, there is a particular case of an implantable multi-
reservoir device, in which chemotherapeutic drugs were released
passively in order to test tumor in vivo sensitivity (Jonas et al.,
2015). The device was implanted through a biopsy needle into
a tumor, and the drugs were directly delivered into the tumor
tissue without systemic exposure. Micromachining of Delrin
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TABLE 2 | Multi-reservoir-based MEMS devices for drug delivery applications.
Actuation
mechanism
Device dimensions Drugs tested Main materials References
NIR
irradiation
27 mm× 11.5 mm× 9.5 mm
(length×width× height)
Human growth hormone MEO2MA-co-OEGMA (POSS)
Graphene oxide nanoparticles
Polyurethane Medical epoxi Parylene C




(diameter) × 3 mm
(length)
Chemotherapeutic drugs: doxorubicin,
sunitinib, lapatinib, antibody cetuximab,
dasatinib, gemcitabine, paclitaxel,
cisplatin
Medical-grade Delrin acetal resin blocks Jonas et al., 2015
Electrothermal (13 × 5.4 × 0.5) mm Human parathyroid Hormone fragment
(1–34) [hPTH(1–34)]
Titanium housing Silicon wafer Ti-Pt Farra et al., 2012
Electrothermal 15 mm× 15 mm× 1 mm Leuprolide Titanium housing Silicon wafer Pt/Ti/Pt
membranes
Prescott et al., 2006
Electrochemical N/S 1,3-bis(2-chloroethyl)-1-nitrosourea
(BCNU)
Silicon wafer Au Pyrex Li et al., 2005
Electrothermal N/S Mannitol Silicon wafer Au or Pt/Ti/Pt membranes Maloney et al., 2005
Electrochemical (17× 17) mm× 310 µm Sodium fluorescein and 45Ca2+ (as
CaCl2)
Silicon wafer Au SiO2 Santini et al., 1999
N/S, not specified; Au, gold; Pt, platinum; Ti, titanium; Cu, copper; PDMS, polydimethylsiloxane: PO, polyolefin; PTFE, poly(tetrafluoroethylene); PZT/PZT-5H, piezoelectric
materials; MDX4-4210, biomedical grade silicon elastomer; SiO2, silicon dioxide.
acetal resin blocks were used for device manufacturing. It consists
of 3–30 circular reservoirs that release the drugs passively into
distinct regions of tumor tissue for 24 h. Appropriate spatial
separation of the reservoirs avoided adjacent drugs overlapping.
Researchers managed to control the release profile of drugs
through several techniques: modification of the reservoir opening
size, use of a polymer matrix in drug formulation to control
the diffusion properties in the tumor, and hydrophilic hydrogels
with expansive capability to eject the drug from reservoirs into
the tumor tissue. Furthermore, a combination of drugs could be
tested by loading them into the same reservoir. Thus, researchers
obtained a device capable of testing up to 16 drug combinations,
which can be used to define which would be optimal drug therapy
before starting a systemic treatment.
Electrochemical Dissolution of Reservoir Capping
Membranes
Electrochemical dissolution is itself an electrolytic process. In
this technique direct electric current is applied externally to
drive a non-spontaneous chemical reaction. In MEMS devices
this reaction offers an effective controlled opening of reservoirs
that can be easily used on drug release applications. Thin
anode membranes cover micro-reservoirs which are filled with
drugs to release. The release mechanism is based on membrane
corrosion processes which allow the delivery of specific doses
of the drug under study which is loaded in those reservoirs
(Zhang et al., 2017).
A solid-state-multiple-reservoir silicon microchip with no
moving parts able to provide controlled release of single
or multiple drugs on demand through the electrochemical
dissolution of capping membranes was first described by Santini
et al. (1999). The main objective of this initial study was to
determine if the pulsatile release of model chemical compounds
could be obtained from the microchip device containing
34 reservoirs. However, the authors stated that device size
(17 mm) had enough surface area to hold until 1,000 reservoirs
and that it could be reduced depending on the application.
Devices were fabricated using silicon wafers and microfabrication
processing techniques including photolithography, electron
beam evaporation, CVD, and RIE. By these, reservoirs that went
through the width of the wafer were generated. The reservoirs
had a square pyramidal shape, with a volume of 25 nL, and were
sealed on their smaller end by a thick gold membrane anode.
Ease of deposition and patterning, low reactivity and corrosion
resistance were the factors that guided the election of gold as a
model material. However, the formation of soluble gold chloride
complexes favored by the presence of a small amount of chloride
ions has been observed. For reservoirs filling, inkjet printing with
a computer-controlled alignment or microsyringe pumps were
used to deposit 0.2 nL of an aqueous solution of a compound
and a liquid polymer into each one. The water was evaporated
after injection and only liquid polymer and model compound
remained in the reservoir. Release from the reservoir was initiated
by applying an electric potential between a cathode and the gold
anode membranes over the reservoirs and was based on the
electrochemical dissolution of this thin anode. Parts of electrodes
were protected from unwanted corrosion produced by the
environment by an isolating silicon dioxide coating produced by
plasma-enhanced CVD and characterized by an adequate density
and adhesion to the gold deposit. This study demonstrated
that the opening of each reservoir can be individually triggered
and that varying amounts of chemicals can be released in a
pulsatile or continuous and sequential or simultaneous manner
from a single device. The biocompatibility and biofouling of the
proposed microfabrication materials were demonstrated in vivo
(Voskerician et al., 2003). However, the potential harmful effects
of soluble gold chloride complexes formed upon dissolution of
reservoir capping membranes was not evaluated.
In another work, a multiple-reservoir device was used
to release carmustine [1,3-bis(2-chloroethyl)-1-nitrosourea
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(BCNU)], a drug used for brain tumors treatment, by an
electrochemical-dissolution-based mechanism (Li et al., 2004,
2005). The drug was co-formulated with polyethylene glycol
to enhance release kinetics. The device was based on 20
micro-reservoirs etched into a silicon substrate and bonded
to a Pyrex structure containing two macro-reservoirs with a
volume capacity of approximately 9 µl. Each macro-reservoir
was physically connected to 10 micro-reservoirs in order to
increase the device capacity. The materials and process for
microfabrication, as well as the actuation mechanism, were the
same as described by Santini et al. (1999). Two drug release
events could take place each time 10 micro-reservoirs were
opened by dissolution of their gold capping membranes to enable
the release of each macro-reservoir contents. The study proposed
a performance comparison between the local delivery of BCNU
from devices, which were implanted next to experimental
gliosarcomas in rats, and subcutaneous injections of the same
drug by evaluating the tumor growth in vivo. The results
indicated that the device activation process was not detrimental
for released BCNU activity and therapeutic benefit. However, the
fact that only two release events can be accomplished constituted
an important limitation of this particular design.
An implantable silicon micro-reservoir device that
enables drug delivery in a controlled manner using a robust
electrochemical mechanism was reported by Chung et al.
(2009). In this case the electric potential was applied between
the reservoirs capping membranes and another electrode at
the inside bottom of the reservoir (Figure 7). This caused
gradual rupture and opening of the capping membranes by gold
dissolution. The electrolytic reaction produced gas release inside
the reservoirs which forced the contents to go out of them. With
this design, less time was required to eject the content out of the
reservoirs, compared to other devices that operate on the same
principle. Also, this device enabled delivery of higher volumes
thanks to the inclusion of Pyrex-PDMS patterned macro-
reservoir extension placed behind the silicon chip. Parylene
coating of PDMS was applied to avoid loss of fluid through the
PDMS substrate. In terms of power requirement, around 5 mW
were required for an ejection rate of c.a. 4 µL/min. However,
in vivo testing of this design remained pending and the authors
suggested applying a surface modification with polyethylene
glycol to minimize physiological response after implantation.
Electrothermal-Based Actuation
The electrothermal activation process involves metal membranes
which are subjected to an applied current. The generation of
local resistive heating causes failure of the membrane and,
therefore, the release of the drug reservoir content. Preferential
heating on the membranes is due to several reasons. The
environment around the suspended membrane possesses lower
thermal conductivity than the substrate. Furthermore, the
material constitution of the membrane may be more resistive
than the trace material, thus increasing heat generation. Besides,
membrane area is smaller than those of the traces, which
increases the current density and heating. In this way, membrane
failure occurs as fast as 5 µs after current application.
The theory and characterization of this actuator was
demonstrated by Maloney et al. (2005), who described the first
electrothermally activated microchip. The device was adapted
from the electrochemically actuated microchip previously
described by Santini et al. (1999), which was the first controlled
release microchip reported. The electrothermally activated device
consists of multiple reservoirs sealed and actuated individually. In
this study, two types of membranes were assessed: gold or three
layers of titanium and platinum (Pt/Ti/Pt). Gold and titanium
materials were selected to exemplify relatively low and high
resistivity materials. Platinum is an inert, noble material, and
had the purpose to protect Ti in vivo and during fabrication,
when several RIE etching steps were used. As it was expected,
researchers demonstrated that less current was needed to rupture
the Pt/Ti/Pt compared to the gold membranes. This was justified
to be the result of the much higher resistivity of Pt/Ti/Pt.
In vitro release of 14C-labeled mannitol demonstrated that this
technology is reproducible and robust. In addition, researchers
suggested that this device may be used for biosensors that are
susceptible to failure caused by biofouling.
These electrothermally activated microchips were connected
to a wireless communication system in order to obtain an
implantable device for controlled pulsatile drug delivery (Prescott
et al., 2006). In this case microchips contained 100 individual
reservoirs of 300 nL each. The release study involved the peptide
leuprolide acetate, which is an analog of a luteinizing hormone-
releasing hormone, used for the treatment of endometriosis and
prostate cancer. The lyophilized leuprolide was formulated in a
matrix of solid polyethylene glycol. Indium tin eutectic solder
were used to seal reservoirs by thermocompression bonding. The
resulting device was implanted subcutaneously in beagle dogs
and peptide release was maintained for 6 months. Leuprolide
bioavailability and the release kinetics parameters were constant
for the whole period. As a conclusion, loading and in vivo
releasing of a solid-phase drug formulation can be fulfilled and
controlled by telemetry. The small volume that can be contained
in the reservoirs could be a limitation for this microchip. As
a result, researchers focused on the study of drugs sufficiently
potent to make them compatible with the volumetric constraints
of the device. Among these drugs, human parathyroid hormone
hPTH is of great interest as a therapeutic agent for osteoporosis.
Proos et al. (2008) successfully prepared clinically efficacious
doses of the 34-amino acid N-terminal fragment of the hPTH,
hPTH(1–34), in a lyophilizable solution phase form that could
be contained in the reservoirs. They demonstrated long-term
stability of this dosage form and consistent, pulsatile release
kinetics was assessed in vitro. This device was further evaluated
in vivo in a clinical trial (Farra et al., 2012). Devices containing
two microchips and a total of 20 doses of lyophilized hPTH(1–
34) were implanted in osteoporotic postmenopausal women
for several months and wirelessly programmed to release daily
doses (Sheybani et al., 2013b). Each microchip included 10
reservoirs (of 600 nL) containing 40 µg doses of hPTH(1–
34). A membrane composed of titanium and platinum was
utilized for electrothermal activation, as previously described
by Maloney et al. (2005). The 20 membranes were connected
to metal contacts, which were used as the path for current
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FIGURE 7 | Cross-section schemes showing the operational steps of an electrochemically actuated drug delivery device: (A) Drug dissolution is loaded in the
reservoirs; the electric potential is applied between top and bottom electrodes. (B) The gold capping membranes are dissolved and the electrolysis of water caused
gas release. (C) The generated bubbles drive the outflow of reservoir contents.
pulses to melt the individual membranes, thereby exposing
the contents of the reservoirs to the surrounding tissue fluid
and promoting drug release. Micro-reservoirs were aseptically
filled with the soluble drug formulation which was further
lyophilized. To provide hermetic seal to microchip assemblies
a compression welding process at room temperature was
utilized, as this was critical for preventing drug degradation.
Hermeticity tests were performed to select the devices for
implantation. The dosage release was programmed using wireless
control and dose scheduling was wirelessly transmitted by the
programmer. The wireless communication connection allowed
knowing implant status information, such as embedded battery
voltage and delivery confirmation (Figure 8). This type of
devices could be benefited by the near-field capacity coupling
for wireless power transmission by which hundreds of milliwatts
of power can be transmitted safely to the implanted device
(Jegadeesan et al., 2017). This was the first in-human study to
prove that electrothermally activated microchips are capable of
programmable dosage release using wireless control. One of the
aims of the study was to evaluate the clinical relevance of the
fibrous capsule formed around the implant, specially whether it
modifies the pharmacokinetic profiles of hPTH(1–34), as it was
presumed to affect diffusion of the drug across the membrane.
The study demonstrated that the device containing hPTH(1–
34) drug combination was biocompatible, was well tolerated by
the patients and was not causal of adverse immune reaction.
The pharmacokinetic profiles from the implant were similar to
the profile of multiple subcutaneous injections, in spite of the
capsule surrounding the implant. Besides, bone formation was
stimulated by the implanted device, evidenced by an increase in
the bone formation marker type I collagen propeptide. Although
this device contained micro-reservoirs only for up to 20 doses,
a larger number of reservoirs would be needed to deliver daily
doses of other drugs for 1 or more years. The cost of this
drug delivery device implanted to provide a medication over the
course of 1 year was expected by the authors to be the same
as other implantable electronic devices, such as pacemakers and
cardioverter defibrillators.
Infrared Radiation-Based Actuation
The use of actuation mechanisms based on non-invasive infrared
radiation began to be investigated very recently. In this sense,
stimulus responsive membranes were used for capping drug
reservoirs in an implantable device (Lee et al., 2019). These
membranes were made of thermosensitive polymer hybrid [POSS
(MEO2MAco- OEGMA)] and photothermal nanoparticles of
reduced graphene oxide. Drug reservoir body, top and bottom
covers were fabricated with a PolyJet 3D printer using
polyurethane copolymer and medical epoxy glue was used to
assemble the constituent parts of the device.
The device was 24 mm in length, 9 mm in width, and 5 mm
in height, occupying a volume of 1 mL approximately. The
prototype arrangement contains 18 drug reservoirs (Figure 9).
Each drug reservoir was 1.5 mm in diameter and 3.5 mm in
height, having a volume of around 6.2 µl. The actuation for drug
release used non-invasive near-infrared irradiation (808 nm)
from the outside skin, which offered high penetration and
no tissue damage. This irradiation produces graphene oxide
excitation that generates heat to break the responsive membranes.
This device was tested with human growth hormone (hGH),
which needs a pulsatile and on-demand delivery regime. In the
implanted device a single and specific drug reservoir could be
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FIGURE 8 | The microchip-based drug delivery device. (A,B) Microchip based hPTH(1–34) drug delivery device (54 mm × 31 mm × 11 mm, l × w × h) (A)
containing two microchips with 10 reservoirs each (13.0 mm × 5.4 mm × 0.5 mm, l × w × h) (B). (C) Schematic cross section of microchip assembly showing drug
releasing from one reservoir. Reproduced from Farra et al. (2012) with permission from The American Association for the Advancement of Science.
open to release a quantity of hGH. Parylene C was used to coat the
whole surface of the device to promote its biocompatibility after
implantation. Each reservoir contained 20 µg of recombinant
hGH and polyethylene glycol which increased its stability. An
external guide for alignment of the infrared irradiation from the
outside body was also fabricated. The device and external guide
were magnetically attached with directionality. The membrane
was aimed to be ruptured just with a 5 s irradiation. To test
device performance in vitro, the responsive membranes were
irradiated with near-infrared light while immersed in buffer at
37◦C for 28 days. To test the in vivo efficacy of hGH delivery,
the device was implanted subcutaneously in hypophysectomized
rats and irradiated on the outside skin once per day for 14 days
after implantation. Although a slight difference was observed
in the time when the maximum hGH concentration in plasma
was reached compared to conventional injection treatment, both
hGH and insulin-like growth factor (physiologically secreted in
response to hGH stimulation) plasma concentrations were not
different between the subcutaneous injection and device groups
at any tested time.
Nowadays, most devices contain the active driving units and
their power source integrated with the drug reservoirs, making
its implantation difficult due to being heavy and bulky. The
proposed device herein sought to improve these aspects by
offering a promising and minimally invasive strategy for on-
demand and pulsatile drug delivery, based on light activation.
Near infrared light wavelength range between 650 and 950 nm
(this device used 808 nm), is considered as one of the optical
windows in biological tissues, also known as therapeutic windows
(Weissleder, 2001; Lane et al., 2018). However, the activation
process to open the reservoirs could appear uncomfortable for
human application, since it supposes the need for a light source




When poor drug absorption or enzymatic degradation in the
gastrointestinal tract or liver turn oral administration of drugs
not feasible, alternative drug delivery systems need to be
considered. An approach that is appealing to patients, remaining
painless as compared to intravenous and intramuscular injections
and offering an easy self-administration and the possibility of
controlled release over time, is the non-invasive drug delivery
across the skin using a patch. In this sense, transdermal drug
delivery (TDD) systems has been being researched since decades
seeking for high bioavailability, controllable plasma levels, and
less overall dose (Rosen et al., 2017; Szunerits and Boukherroub,
2018). However, the TDD has been greatly limited since most
drugs, especially macromolecules, cannot enter the skin in
therapeutically useful doses. Different approaches, such as the
use of chemical enhancers (e.g., lipids, glycols) or physical
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FIGURE 9 | Description of the device and external guide. (A) Three-dimensional schematic of the device and external guide. (B) Working principle of the device: 1 –
the near-infrared light is irradiated through the external guide aligned with the implanted device; 2 – the stimulus responsive membrane capped on the selected drug
reservoir is ruptured and opened; and 3 – the hGH is released. (C) Optical images of the device and external guide (scale bar: 1 cm). Reproduced from Lee et al.
(2019) with permission from the National Academy of Sciences of the United States of America.
methods (e.g., iontophoresis, electroporation, ultrasound) have
been explored to increase skin permeability. Beyond their
differences, these methods share the aim of creating pathways
of sufficient size for drug molecules to go through the stratum
corneum. These are large enough to permit transport of small
drugs and, in some cases, macromolecules, and small enough
to prevent damage of clinical significance (Prausnitz, 2004).
These approaches, however, have shown critical weaknesses.
Physical methods require additional equipment and conventional
TDD systems using chemical enhancers have failed in providing
a precisely self-controlled pharmacological behavior and high
delivery efficiency due to absorption and permeation limitations.
An approach involving the generation of larger transport
pathways through skin by using arrays of microscopic needles
(with a length lower than 1 mm) as TDD MEMS was suggested
to address these issues by improving drug delivery efficiency and
control (Indermun et al., 2014). The motivation for microneedles
(MNs) was generally related to the fact that they can offer
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FIGURE 10 | Schematic view of different strategies for transdermal drug delivery using microneedles (MN).
minimally invasive facilitated transport of macromolecules into
the skin by enhancing its permeability, while remaining safe,
painless and liable to be self-administered. They can also offer
site-specific drug release with a reduced dosing frequency and
maintenance of constant drug concentrations. MEMS based TDD
systems are mainly based on the use these structures and different
approaches are used when applying these structures for drug
delivery (Chen et al., 2016). In the case of solid MNs the skin
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is pretreated and then the drug diffuses through the pores in
the skin from a topical drug delivery system. When drug-coated
MNs are used, after insertion, the coating containing the drug
dissolves in the skin. Another category is formed by arrays of
aqueous-soluble MNs which perforate the skin and release the
drug after MN dissolution. Meanwhile, hollow MNs are like
conventional needles but shorter and are used to deliver liquid
formulations (Figure 10).
An interesting design of a TDD system using modular
reservoirs for drug storage was fabricated and characterized
(Cantwell et al., 2014). The device is composed of two parts, a
modular reservoir constituted by single-use disposable cartridge
and a main structure with integrated MEMS-based drug delivery
system. The idea is that prior to attaching to the skin, the
filled modular reservoir and main part would be manually
assembled. The main structure had several components: an upper
hollow MN which was connected to the modular reservoir
through a septum on assembly, a lower hollow MN array
which enabled minimally invasive TDD, micropumps, valves,
control circuitry, and power source, which enable controllable
extraction of drug loaded in the modular reservoir. The
modular reservoir was formed by a silicon interface plate,
a PDMS membrane and an acrylic cap. The materials were
carefully selected. The factors that guided the use of silicon
included rigidity and versatility for batch microfabrication.
PDMS was selected owing to its elastomeric nature, its
optical transparency, micromolding capacity, and compatibility
with drug formulations. From its part, acrylic offered optical
transparency, rigidity, machinability, and low vapor permeability.
The interface plate was based on a silicon core surrounded by
thin PDMS layers and was a rigid enclosure for the loaded
drug and included PDMS-based septum for filling and draining
of the modular reservoir by a hollow MN. The acrylic cap
contained a vent hole which was sealed with polyimide tape
after the reservoir was filled. This modular reservoir was
designed to load 400 µl of insulin for a 12-h delivery but
the authors considered this design could be adjusted to other
fill volumes. Salient features of this modular reservoir concept
included reproducible delivery and very low fluid loss during
the storage.
Interestingly, some fundamental studies analyzed changes in
mechanical forces and moments of silicon MNs when inserted
in soft tissues, for their effective and safe use (Rajeswari
and Malliga, 2014, 2015). This mechanical interaction was
shown to be affected by forces and moments in diverse
directions, as well as mechanical and geometric properties
of MNs itself. An analytical model allowed understanding
the effect of microneedle geometry on the necessary force
to insert MNs into the human skin. The performed analyses
suggested that the optimal length for silicon MNs is around
300 µm and that smaller lengths would reduce the pain during
insertion. This study particularly described interfacial contact
forces following the puncture event and evaluated the stresses
exerted on the MN and highlighted that understanding of
proper modeling of fracture resistance and failure mechanics
is vital to improve the safety margin. In this regard, it
is to note that microneedle optimization scaling is strongly
dependent on multiple parameters such as fabrication materials,
skin thickness and action area (Al-Qallaf and Das, 2009;
Chen S. et al., 2020).
More recently, an interesting approach described the
fabrication of long (158 µm) and tapered solid silicon
MNs, achieved by optimization of etching process using
tetramethylammonium hydroxide (TMAH) (Narayanan and
Raghavan, 2017). Variation of reactive concentration, etching
time and rates, temperature, and optical mask design were
considered. Among them, the temperature and the position
of the sample in the etching solution showed to be of critical
importance to obtain high aspect ratio MNs. Hardness tests
revealed that the fabricated MNs satisfied the requirements of
mechanical stability to penetrate into the skin.
Materials other than silicon were also considered for MN
fabrication. One of these studies described the fabrication
and analysis of hollow and tubular hafnium oxide MN.
Their fabrication was based on deep reactive ion etching and
atomic layer deposition, and required only one mask (Zhang
et al., 2018a). This study mainly analyzed MNs flexibility and
concluded that this feature could be tuned depending on the
required application. Another relevant studies, reported the
design, fabrication and characterization of a hollow glassy carbon
MN array (Pramanick et al., 2016) with flow channel integration
(Mishra et al., 2018). The strategy was based on the direct laser
writing patterning of photoresist as precursor and conversion
of these structures into glassy carbon by pyrolysis retaining
their tubular MN shape. These MNs were 500 µm for long,
had an outer diameter of 100 µm, and an inner diameter of
40–90 µm (Figure 11). The maximum forces carbon MNs can
endure showed to be approximately two orders of magnitude
higher than the resistive forces presented by the skin. When
a MN array was inserted into mouse skin multiple times, it
was successfully removed without the breakage of any MN.
Microfluidic conduits were fabricated in a silicon substrate by
conventional wet chemical etching and fabricated MNs were
aligned with the reservoir outlet. A cost-effective system to deliver
drugs to patients in a precise and painless manner using this
design would need the combination of the MN array with a
micropump and drug reservoir.
Although many materials such as silicon, metals and glassy
carbon have been used for MN fabrication and were tested
in vivo in the past (Mikszta et al., 2002; Martanto et al., 2004),
these failed on their biodegradability and exhibit some safety
issues. Instead, polymers [e.g., hyaluronic acid, poly(lactic-co-
glycolic acid), gelatin methacryloyl], offer solutions to these
issues, also being their use in the fabrication of MNs simpler and
more cost-effective than that of the aforementioned materials.
The geometry, as well as chemical and physical properties of
polymeric MNs can be fine-tuned for optimal monitoring (Zhu
et al., 2020), regeneration therapies (Lee et al., 2020), or TDD
applications (Singh et al., 2019).
Several techniques have been proposed for fabrication
of polymeric microneedles, being micromolding, drawing
lithography, electro-drawing and droplet-borne air blowing
among the most widely used. Micromolding involves replication
of a master template which can ultimately yield many MN
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FIGURE 11 | (A) Hollow microneedles puncture the skin to reach above the pain-sensing nerves in the transdermal region of the skin and painlessly release the drug
through suitable actuation methods. The figure in the outset shows a magnified view of the microneedle structure proposed in this work. (B) a: schematic of the
microneedle insertion test on mice; b: biological insertion test performed on 6- to 8-week-old Swiss Albino mice; c: magnified view of the skin area pierced by the
glassy carbon microneedles; d: intact array of 10 × 10 after multiple insertions. (C) a: Etched microfluidic conduit in silicon through which the drug flows from the
drug reservoir to the glassy carbon microneedles; b: SU-8 microneedles fabricated on a microfluidic conduit backside of the image shown in a; c: glassy carbon
microneedles array formed after pyrolysis; d: magnified view of a glassy carbon microneedles; e: optimized glassy carbon microneedles aligned on etched
microfluidic ports on a silicon wafer. Adapted from Mishra et al. (2018) with permission from Springer Nature (http://creativecommons.org/licenses/by/4.0/).
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arrays following several steps. Use of heat or UV light
during the procedure can critically affect the loaded drugs.
However, it is a simple, reproducible and scalable process
and some improvements have been recently reported (Chen
Y. et al., 2020). Drawing lithography is a direct patterning
process based on viscosity and elastic deformation of polymers
in glass transitions, thereby avoiding the need of mask
and light irradiation but requiring polymer curing and with
limitations when biodegradable materials are intended to
be used (Lee and Jung, 2012). Electro-drawing is another
mold- and UV-free technique, which adds the contact-free
feature and uses an electrohydrodynamic driving force in
mild-temperature conditions. It has been useful for MN
fabrication using biodegradable materials (Vecchione et al.,
2014; Ruggiero et al., 2018). Droplet-borne air blowing is
another fast and mild-temperature fabrication process in which
MNs are formed by air blowing and drying of microdroplets
contacting two surfaces while these are being separated
(Kim et al., 2013).
Most recent contributions of polymeric MNs in TDD
applications include the sustained release of contraceptive drugs
(e.g., progestagens) by either a drug-loaded polylactic acid and
poly(lactic-co-glycolic) acid microneedle patch coated by a drug-
free polymer film (Li et al., 2019) or by a multiple-layer MN
patch for slow dissolution (He M. et al., 2018; Donnelly and
Larraòeta, 2019). Prolonged release of chemotherapeutics (e.g.,
doxorubicin) was also achieved by drug loading into gelatin
methacryloyl MNs using one molding step (Luo et al., 2019).
Burst drug release was also possible by using highly dissolvable
MN patches. Examples of this are the rapid release of acyclovir
for the treatment of herpes labialis (Pamornpathomkul et al.,
2018), of dihydroergotamine mesylate for the management of
acute migraine (Tas et al., 2017) and of vitamin K during
bleeding (Hutton et al., 2018). When targeted release was
sought stimuli-responsive MN systems could offer alternatives
too. MN patches fabricated using a hydrogen peroxide-labile
copolymer encapsulating insulin and glucose oxidase, were
able to release insulin under hyperglycemic conditions (Zhang
et al., 2018b). In contrast, enzyme-free glucose-responsive MN
array for insulin delivery was achieved by a using boronate
hydrogel and biocompatible silk fibroin for fabrication (Chen
et al., 2019). Another example of targeted delivery was the
delivery of STAT3 siRNA for the treatment of melanoma by
dissolving polyethylenimine MNs (Pan et al., 2018). Polymer
FIGURE 12 | Needle-free injection process: (A) Location of the device in the selected area. No need for needle insertion into the skin. (B) Shooting of the jet out of
the nozzle at high speed (>100 m s−1) owing to the impact of a piston on a liquid reservoir. The impact of the jet on the skin surface forms a hole in the skin by
erosion or fracture. (C) The continuous impact of the jet increases the depth of the hole in the skin. The liquid that has accumulated in the hole slows the incoming
jet. The liquid disperses in the skin due to the stagnation of the jet at the end of the hole.
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MNs have also been used recently for vaccine delivery. A MN
patch layer-by-layer coated with a synthetic pH-induced charge-
invertible polymer was successfully used for a rapid release of
an antigen and induction of an elevated immune response (He
Y. et al., 2018). Enhanced cancer immunization was achieved
by dissolving MNs based on an amphiphilic triblock copolymer,
which generated nanomicelles containing a model antigen (OVA)
and a vaccine adjuvant (R848) upon insertion in the skin
and dissolution (Kim et al., 2018). Photothermal activation
was also applied for induced release of the antidiabetic drug
metformin which was incorporated with bismuth nanodots in
poly(vinylpyrrolidone) dissolving MNs (Liu et al., 2018).
Biodegradable polymeric MNs can be effectively activated for
drug release by exploiting the polymer and encapsulated drug
properties. Their efficiency, cost-effectiveness and the ease of
self-administration by patients must be highlighted. However,
their precise and uniform large-scale manufacturing remains a
challenge and requires further technological innovation.
Needle-Free Injectors for Drug Delivery
Needle injection has been one of the main drug delivery
mechanisms for intravenous, intramuscular or subcutaneous
administration of drugs. However, it exposes some disadvantages
like no compliance to the treatment, a degree of phobia,
damage and pain caused by injection, among others. All
these stimulated research to generate new and more efficient
strategies (Berrospe-Rodriguez et al., 2016). In this context, in
addition to microneedle-based technology previously exposed,
some needle-free systems also aimed at solving these problems
were developed. Needle-free jet injectors are currently one of
the effective alternatives to conventional needle injections, with
multiple commercial devices cited in clinical trials (Bremseth
and Pass, 2001; Yousafzai et al., 2017; Bavdekar et al., 2019).
TDD based on this mechanism entails ejection of a liquid drug
through a fine nozzle at elevated pressure, thus generating a
narrow super-fast fluid jet easily penetrable into the skin and
tissue (Figure 12).
In the literature, researchers have explored different actuation
mechanisms to generate a steady and high speed jet. In this
sense, the design and simulation of a simple and compact
piezoelectric actuated needle free injector which offers control of
microliter injection volume was recently reported (Trimzi et al.,
2019). The analysis demonstrated the dependency of the injection
dynamics on parameters such as impulse force, nozzle diameter,
and length. The idea of this study was that multiple layers of
piezoelectric actuator would instantly expand and move the fluid
through a fine nozzle, avoiding the use of a needle injector.
Also, as the applied voltage determined the expansion of the
piezoelectric layers, this experimental variable could be used to
electronically control the injection volume and directly affected
the jet formation phenomenon.
Furthermore, some in vitro research studies on needle-free
jet injection dynamics were recently published (Rohilla and
Marston, 2019; Zeng et al., 2019). These analyzed the influence
of nozzle orifice diameter, of the injection volume, of the liquid
viscosity, of tissue stiffness and of the standoff distance between
the nozzle orifice and the skin surface on the jet injection
dispersion pattern and penetration depth in the tissue. Width
and length diffusion region would be influenced by the ejection
volume and the orifice diameter, respectively. Conspicuously, one
of these studies showed that fluid penetration depth was increased
by increasing the standoff distance between the nozzle orifice and
a gel surface, which could dependent on the model surface used.
Among in vivo studies, needle-free drug delivery systems
have been recently used to deliver vaccines to the sublingual
and buccal tissue of rhesus macaques by using a commercially
available needle-less injector and, in this way, to test the viability
as an effective and practical route of administration to induce
immunity against HIV-1 (Jones et al., 2019). In addition, needle-
free injectors have been tested in Chinese patients with type
2 diabetes (Xing et al., 2019). In this trial, insulin glargine
was administered by another commercially available needle-
free injector for 1–2 weeks. Interestingly, patients who received
the needle-free administration demonstrated less discomfort,
fear and pain than patients receiving conventional needle-based
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injections. Also, the insulin dose required for glycemic control
was reduced by using the needle-free system and it was a
positively correlated with the degree of that dose reduction. This
study determined that needle-free injection system would reduce
the adverse effects of high insulin doses, topical reactions and fear
of injections, which should help improving patient compliance
to this treatment.
In addition to reduce pain and stress, this technology avoids
needle disposal, enables self-administration and has been show
to offer consistent delivery of vaccines and other medications.
Its main drawback is the remaining moisture of the skin after
administration, which can, if not taken care of, harbor dust and
other adverse impurities.
DISCUSSION
During the past few years an interesting number of new
micro-electro-mechanical devices for controlled drug release
applications have emerged. Indeed, the unique physical and
analytical functions together with electrical components and
aseptically manufacture suggest that they have important
applications in medicine, especially as therapeutic agents
delivery systems. At the forefront of research in this area
is the development of actuation mechanisms to deliver the
pharmaceutically cargo in controlled and exact doses. Moreover,
considerable effort has been devoted to the design and
fabrication of these devises, including single or multiple
reservoirs, implantable or transdermal devices and to marry these
novel micro-electro-mechanical devices with the sophisticated
characteristics of biological systems, in order to achieve an
effective delivery of therapeutic agents in vivo.
The different studies presented in this review highlight the
potentialities of these devices with different engineering designs
and actuator mechanisms and that the application of MEMS
devices for controlled drug release is an emerging field with
important implications in human healthcare. Table 3 summarizes
the advantages, disadvantages and final applications of the
implantable and transdermal described MEMS devices. Some
of them showed prolonged and/or controlled release profiles
of therapeutic compounds such chemotherapeutic drugs and
hormones but only reached the in vitro stage needing further
research. Others, especially those based on multi-reservoir
design, were tested in vivo and a reduced number of them
have been tested in human clinic trials. In this sense, it is
important to note that these devices are especially desirable
and useful in the case of providing release of high potent
drugs which evoke a given response at very low concentrations.
That offers the possibility to load higher individual doses of a
given drug in ultra-minimally invasive devices and to release it
for longer periods of time. Alongside, biodegradable polymeric
microneedles and needle-free injection technology allow painless
and cost-effective transdermal drug administration, increasing
patient compliance. Although many advances have been made
on device miniaturization, biocompatibility, remote control,
operating autonomy, low energy consumption, programming
of varied release profiles, controlled and/or pulsatile release
for prolonged periods of time, there is still no such versatile
device to date that can gather all these interesting properties.
In view of the traveled path, it is envisioned that further
investigations and technological developments would make this
a reality in a short time.
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